(Q36942366)

17 August 2017

Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis (English)

1 reference

17 August 2017

5

John D Reveille

1 reference

17 August 2017

Xiaochun Liu

1

1 reference

17 August 2017

Maureen D Mayes

2

1 reference

17 August 2017

Filemon K Tan

3

1 reference

17 August 2017

Minghua Wu

4

1 reference

17 August 2017

Brock E Harper

6

1 reference

17 August 2017

Hilda T Draeger

7

1 reference

17 August 2017

Emilio B Gonzalez

8

1 reference

17 August 2017

Shervin Assassi

9

1 reference

17 August 2017

1 January 2013

1 reference

17 August 2017

Arthritis & Rheumatology

1 reference

17 August 2017

65

1 reference

17 August 2017

1

1 reference

17 August 2017

226-235

1 reference

Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Type I interferon system activation and association with disease manifestations in systemic sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Dissecting interferon-induced transcriptional programs in human peripheral blood cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Systemic sclerosis and lupus: points in an interferon-mediated continuum

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Systemic sclerosis - continuing progress in developing clinical measures of response.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Changes in causes of death in systemic sclerosis, 1972-2002

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Autoantibodies in systemic sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

The assessment of the patient with systemic sclerosis. Introduction.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Systemic sclerosis developing in association with the use of interferon alpha therapy for chronic viral hepatitis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3687352

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FART.37742

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FART.37742

Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

12 December 2020

A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists

1 reference

12 December 2020

CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study

1 reference

12 December 2020

Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma

1 reference

12 December 2020

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

1 reference

12 December 2020

Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders

1 reference

12 December 2020

A disease severity scale for systemic sclerosis: development and testing

1 reference

12 December 2020

Identifiers

DOI

10.1002/ART.37742

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

23055137

1 reference